Our vision at ViroPharma as a multinational pharmaceutical company is to be recognized worldwide for developing and marketing innovative products addressing unmet medical needs. We strive everyday to improve the lives of patients through delivering medicines that address serious unmet medical needs. Our goal is simple in that we dedicate ourselves to develop and market products that address underserved, life-threatening conditions such as cytomegalovirus and C. difficile.
ViroPharma makes the following information available to journalists – and anyone else – interested in learning more about ViroPharma, who we are, and why we do what we do.
Media Contacts
Kristina Broadbelt; Assistant Director, Public Relations and Advocacy
(610) 321-2358
(This is for journalist and media inquiries only. If you are not a journalist, and are calling with a general question about ViroPharma, please dial our main number: 610-458-7300.)
Press Kit
Fact Sheet (HTML | PDF)
Overview of cytomegalovirus (CMV) (PDF)
Overview of Hepatitis C (PDF)
Overview of Clostridium difficile (PDF)
Senior Management and Board of Directors (PDF)
Logos (ZIP)
Media FAQ (PDF)